Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Fleming CW"'
Autor:
Lee MY; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA., Belfiglio M; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA., Zeng J; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA., Fleming CW; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Koyfman S; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Joshi NP; Department of Radiation Oncology, Rush University Medical Center, Cleveland, Ohio, USA., Lamarre E; Head and Neck Cancer Program, Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA., Prendes B; Head and Neck Cancer Program, Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA., Scharpf J; Head and Neck Cancer Program, Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA., Lorenz RR; Head and Neck Cancer Program, Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA., Woody NM; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Adelstein DJ; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Geiger JL; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Chute DJ; Department of Pathology, Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, Ohio, USA., Ku JA; Head and Neck Cancer Program, Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA.
Publikováno v:
The Laryngoscope [Laryngoscope] 2023 May; Vol. 133 (5), pp. 1122-1131. Date of Electronic Publication: 2022 Jun 26.
Autor:
Smile TD; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A.; smilet@ccf.org., Reddy CA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Matia B; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Fleming CW; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Domb C; Case Western Reserve University College of Medicine, Cleveland, OH, U.S.A., Geiger JL; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Joshi NP; Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, U.S.A., Woody NM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Chute DJ; Department of Pathology, Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Griffith CC; Department of Pathology, Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Adelstein DJ; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Koyfman SA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A.
Publikováno v:
Anticancer research [Anticancer Res] 2022 Aug; Vol. 42 (8), pp. 3845-3852.
Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer.
Autor:
Mayo ZS; Cleveland Clinic Department of Radiation Oncology, Cleveland, OH, U.S.A., Ilori EO; Cleveland Clinic Department of Radiation Oncology, Cleveland, OH, U.S.A., Matia B; Cleveland Clinic Department of Radiation Oncology, Cleveland, OH, U.S.A., Smile TD; Cleveland Clinic Department of Radiation Oncology, Cleveland, OH, U.S.A., Fleming CW; Cleveland Clinic Department of Radiation Oncology, Cleveland, OH, U.S.A., Reddy CA; Cleveland Clinic Department of Radiation Oncology, Cleveland, OH, U.S.A., Scharpf J; Cleveland Clinic Department of Otolaryngology, Cleveland, OH, U.S.A., Lamarre ED; Cleveland Clinic Department of Otolaryngology, Cleveland, OH, U.S.A., Prendes BL; Cleveland Clinic Department of Otolaryngology, Cleveland, OH, U.S.A., Ku J; Cleveland Clinic Department of Otolaryngology, Cleveland, OH, U.S.A., Burkey BB; Cleveland Clinic Department of Otolaryngology, Cleveland, OH, U.S.A., Joshi NP; Rush University Medical Center, Department of Radiation Oncology, Chicago, IL, U.S.A., Woody NM; Cleveland Clinic Department of Radiation Oncology, Cleveland, OH, U.S.A., Koyfman SA; Cleveland Clinic Department of Radiation Oncology, Cleveland, OH, U.S.A., Campbell SR; Cleveland Clinic Department of Radiation Oncology, Cleveland, OH, U.S.A.; campbes6@ccf.org.
Publikováno v:
Anticancer research [Anticancer Res] 2022 Apr; Vol. 42 (4), pp. 1845-1849.
Autor:
Wu SS; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA., Chen B; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA., Fleming CW; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Shah AA; Department of Pathology, Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA., Griffith CC; Department of Pathology, Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA., Domb C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Reddy CA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Campbell SR; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Woody NM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Lamarre ED; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA., Lorenz RR; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA., Prendes BL; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA., Scharpf J; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA., Schwartzman L; Department of Hematology & Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Geiger JL; Department of Hematology & Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Koyfman SA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Ku JA; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Publikováno v:
Head & neck [Head Neck] 2022 Apr; Vol. 44 (4), pp. 851-861. Date of Electronic Publication: 2022 Jan 18.
Autor:
Domb C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Smile TD; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Reddy C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Woody NM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Campbell SR; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Canavan JF; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Joshi NP; Department of Radiation Oncology, Rush University Cancer Center, Chicago, IL, U.S.A., Greskovich JF; Department of Radiation Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL, U.S.A., Chute DJ; Department of Pathology, Cleveland Clinic, Cleveland, OH, U.S.A., Burkey BB; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Ku LA; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Lamarre E; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Lorenz RR; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Prendes B; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Scharpf J; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Schwartzman L; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, U.S.A., Geiger JL; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, U.S.A., Koyfman SA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Fleming CW; Department of Radiation Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL, U.S.A.; cfleming654@gmail.com.
Publikováno v:
Anticancer research [Anticancer Res] 2021 Oct; Vol. 41 (10), pp. 4995-5000.
Autor:
Fleming CW; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States. Electronic address: fleminc@ccf.org., Ward MC; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Woody NM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States., Joshi NP; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States., Greskovich JF Jr; Department of Radiation Oncology, Cleveland Clinic Florida, Weston, FL, United States., Rybicki L; Department of Quantitative Health Sciences, Cleveland Clinic Learner Research Institute, Cleveland, OH, United States., Xiong D; Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States., Contrera K; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Chute DJ; Department of Pathology, Cleveland Clinic, Cleveland, OH, United States., Milas ZL; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Frenkel CH; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Brickman DS; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Carrizosa DR; Department of Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Ku J; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Prendes B; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Lamarre E; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Lorenz RR; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Scharpf J; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Burkey BB; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Schwartzman L; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States., Geiger JL; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States., Adelstein DJ; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States., Koyfman SA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States.
Publikováno v:
Oral oncology [Oral Oncol] 2021 Jan; Vol. 112, pp. 105046. Date of Electronic Publication: 2020 Oct 28.
Autor:
Fleming CW; Department of Radiation Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, 9500 Euclid Avenue/CA-50, Cleveland, OH, 44195, USA. fleminc@ccf.org., Broughman JR; Department of Radiation Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, 9500 Euclid Avenue/CA-50, Cleveland, OH, 44195, USA., Tendulkar RD; Department of Radiation Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, 9500 Euclid Avenue/CA-50, Cleveland, OH, 44195, USA.
Publikováno v:
Current treatment options in oncology [Curr Treat Options Oncol] 2020 Nov 20; Vol. 22 (1), pp. 2. Date of Electronic Publication: 2020 Nov 20.
Autor:
Broughman JR; Dr. Broughman is a PGY4 chief resident, Dr. Fleming is a PGY5 resident, and Dr. Stephans, Dr. Mian, and Dr. Tendulkar are associate staff, all in the Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, OH., Fleming CW; Dr. Broughman is a PGY4 chief resident, Dr. Fleming is a PGY5 resident, and Dr. Stephans, Dr. Mian, and Dr. Tendulkar are associate staff, all in the Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, OH., Mian OY; Dr. Broughman is a PGY4 chief resident, Dr. Fleming is a PGY5 resident, and Dr. Stephans, Dr. Mian, and Dr. Tendulkar are associate staff, all in the Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, OH., Stephans KL; Dr. Broughman is a PGY4 chief resident, Dr. Fleming is a PGY5 resident, and Dr. Stephans, Dr. Mian, and Dr. Tendulkar are associate staff, all in the Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, OH., Tendulkar RD; Dr. Broughman is a PGY4 chief resident, Dr. Fleming is a PGY5 resident, and Dr. Stephans, Dr. Mian, and Dr. Tendulkar are associate staff, all in the Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, OH.
Publikováno v:
Applied radiation oncology [Appl Radiat Oncol] 2020 Sep; Vol. 9 (3), pp. 6-10. Date of Electronic Publication: 2020 Sep 09.
Autor:
Canavan JF; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States. Electronic address: canavaj@ccf.org., Harr BA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Bodmann JW; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Reddy CA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Ferrini JR; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Ives DI; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Chute DJ; Department of Pathology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Fleming CW; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Woody NM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Geiger JL; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Joshi NP; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Koyfman SA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States., Adelstein DJ; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States.
Publikováno v:
Oral oncology [Oral Oncol] 2020 Apr; Vol. 103, pp. 104585. Date of Electronic Publication: 2020 Feb 07.
Autor:
Fleming CW; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA., Parsai S; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA., Suh JH; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Publikováno v:
Translational cancer research [Transl Cancer Res] 2019 Feb; Vol. 8 (1), pp. 1-3.